COMMUNIQUÉS West-GlobeNewswire

Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
11/05/2026
New company (“NewCo”) co-founded by Nxera with a syndicate of leading healthcare and life sciences-focused investment firms. In return for granting an exclusive worldwide license to the program, Nxera is eligible to [...]
Bavarian Nordic – Completion of Share Buy-Back Program
11/05/2026
COPENHAGEN, Denmark, May 11, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on March 12, 2026, has now been completed, reaching an aggregate amount of [...]
Leo International Precision Health AG: Planned nine acquisitions in Asia and Europe for inorganic growth
11/05/2026
Leo International Precision Health AG / Keyword: Mergers and Acquisitions / Purchase of parts of a company Leo International Precision Health AG: Planned nine acquisitions in Asia and Europe for inorganic growth 11. May [...]
Positive Results from PulseSight’s Phase I Clinical Trial of PST-611 in Dry AMD/Geographic Atrophy Presented at ARVO 2026
11/05/2026
PARIS, May 11, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology [...]
Pulsetto Vagus Nerve Stimulator 2026 Claims, Features, and Feedback Under Investigation
11/05/2026
Hillsborough, NJ, May 11, 2026 (GLOBE NEWSWIRE) -- Stress is something a lot of people deal with every day, whether it’s school, work, family pressure, or just trying to meet daily responsibilities. For students, it can [...]
RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
10/05/2026
Total Company Revenue increased 22.1% to $575.6 million in the first quarter of 2026 from $471.4 million in the first quarter of 2025 Revenue from the Digital Health reportable segment increased 51.5% to $29.1 million [...]
MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
10/05/2026
MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where MoonLake and the FDA aligned on submission plans and the label strategy for [...]
WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure
10/05/2026
Six-month clinical data from 40 patients highlights safety, effective decongestion, stable renal function, and reduced rehospitalizations using the eLym™ System GALWAY, Ireland, May 10, 2026 (GLOBE NEWSWIRE) -- [...]
A Pint for Kim Blood Drive Breaks Illinois Record for the Seventh Year in a Row with over 650 Donations in One Day
10/05/2026
National Grassroots Movement has secured tens of thousands of pints of blood, all in honor of a mom who lost her eight-year battle with rare cancer NAPERVILLE, Ill., May 09, 2026 (GLOBE NEWSWIRE) -- A Pint for Kim , the [...]
Asuno Launches Sleep & Energy Patches to Address Rising Consumer Demand for Wellness Solutions
09/05/2026
NEW YORK, May 09, 2026 (GLOBE NEWSWIRE) -- Asuno today announced the launch of its new line of Sleep and Energy Patches, expanding its footprint in the fast-growing wellness sector as consumers increasingly seek [...]
Open Peer-Review Exposes UPV Ethics Committee’s Dilemma: Suppress a 33 Year Recognized Breakthrough or Acknowledge Reviewer’s Ethical Violations and Remit Final Judgement to the Known Dataset Test to Save Millions of Lives and Billions of Euros
09/05/2026
Crosetto Foundation calls for public transparency after TBPET reviewers rejected a Known Dataset Test abstract while failing to refute its calculations, technical evidence, or documented comparisons. DALLAS, May 08, [...]
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
09/05/2026
Melbourne, Australia, May 08, 2026 (GLOBE NEWSWIRE) -- HIGHLIGHTS Amplia and ANZGOG enter into agreement to conduct a clinical study in ovarian cancer evaluating narmafotinib in combination with standard-of-care [...]
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
09/05/2026
May 8, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research [...]
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
09/05/2026
ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the LD Micro [...]
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
08/05/2026
MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
08/05/2026
-- With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices -- ATLANTA, May 08, 2026 (GLOBE [...]
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026
08/05/2026
REGULATED INFORMATION May 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “ Company ”) Invitation to attend the annual [...]
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
CHAPEL HILL, N.C., May 08, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
BEDFORD, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced [...]

Pages